Abstract. Thermal balneotherapy with Cornano spa's water (CW; Trentino, Italy) is used for psoriasis and other skin disorders but thè mechanism(s) of action of this hypotonic water are unknown. Since skin psoriatic manifestations are thought to be angiogenesis-dependent, we assessed CW's effects on thè expression and release of VEGF-A protein isoforms by cultured human lesionai keratinocytes isolated from skin biopsies performed in 9 patients. Confluent, psoriatic keratino cytes were exposed for 11 days to DMEM, whose chemicals had been dissolved in either deionised water (DW-DMEM, 
Introduction
Psoriasis, a chronic inflammatory dermatosis affecting approximately 2% of thè Western population, is clinically marked by relapsing-remitting manifestations of well-defined, symmetrical erythematous plaques covered by scales. Although it has a genetic basis, thè pathogenesis of psoriasis remains unclear.
Currently, psoriasis is believed to be a T lymphocyte-driven disorder (1). However, at skin lesionai sites, early prominent proliferation of a particular subset of endothelial cells lining thè venous limbs of capillary plexuses in thè upper dermal papillae leads to thè formation of tortuous, dilated, inflamed, and hyper-permeable vessels (2,3). As these vascular changes precede thè plaque's epidermal hyperplasia and dermal infiltration by inflammatory cells (i.e. neutrophils, T lymphocytes, monocytes) (4,5), it has been surmised that psoriasis is an angioproliferative ailment depending upon thè release of angio genic molecules by thè epidermis (6-11). Increased amounts of several angiogenic cytokines, including transforming growth factor-a (TGF-a), tumour necrosis factor-a (TNF-a), interleukin-1 (IL-1), amphiregulin, derived endothelial celi growth factor/thymidine phosphorylase (TP), endothelial celi stimulating angiogenesis factor (ESAF), and VEGF-A are produced and secreted by thè psoriatic keratinocytes (9, (12) (13) (14) (15) (16) (17) (18) (19) .
VEGF-A, thè archetypal and best characterized member of a family of angiogenic growth factors (20, 21) , acts both as an Cornano (Trentino, Italy) spa's water (CW) is a thermal hypotonic water containing various electrolytes (Table I) . with a rabbit polyclonal anti-VEGF-A antibody (final dilution 10 /jg-ml"1; Santa Cruz Biotechnology, Ine, Germany glycosylation levels), and L-VEGF-A|89 (55 kDa) isoforms ( Fig. 2A ) (35) (36) (37) 64) . Thè densitometric analysis of thè specific bands showed that, in cells exposed to both media, thè amounts of L-VEGF-A189, thè most intensely expressed isoform, and VEGF-A165 48 kDa underwent significant time-related changes ( Fig. 2B and C) . In fact, L-VEGF-A189 48 kDa levels at day 3 were 4-fold higher (p<0.001) in contrai (DW-DMEM) than in treated (CW-DMEM) keratinocytes, but thè opposite was true 8 days later, when L-VEGF-A,89 levels had fallen to onefourth of their starting values in DW-DMEM-kept (contrai)
cells, yet had increased more than 4-fold in CW-DMEMexposed (treated) keratinocytes (p<0.001 vs. day 3 values in either instance) (Fig. 2B) . Though being identical at day 3, VEGF-A165 48 kDa levels fell significantly in thè keratinocytes grown in DW-DMEM, while increasing in thè cells kept in CW-DMEM (Fig. 2C) . Evaluating thè areas under thè respective curves made it clear that, between days 3 and 11, thè total intracellular and/or cell-bound levels of L-VEGF-A l89
and VEGF-AI6J 48 kDa were greater in CW-DMEM-incubated than in DW-DMEM-exposed keratinocytes (Fig. 3A) . did not significantly change and dici not differ between keratinocytes kept either in DW-DMEM or in CW-DMEM ( Fig. 2D and E, Fig. 3A ).
Effects of exposure to DW-DMEM or to CW-DMEM on -A,2i isoforms (33,66,67) . These bands were subjected to densitometric analysis (Fig. 4) .
Thè sVEGF-A 24 kDa band was thè thickest one in either DW-or CW-DMEM, keratinocyte-conditioned media, in both of which, excepting at day 11, it behaved similarly ( Fig. 4A and B). There occurred a peak of sVEGF-A 24 kDa protein at day 5 (a 2-fold increase over starting levels: p<0.001),
followed by a rapid drop to approximately one-third of thè initial level at day 7 (p<0.001 in either instance vs. day 3 values) in both kinds of medium. But, at day 11, thè amount of sVEGF-A 24 kDa protein was significantly lesser (-31%, p<0.05) in CW-DMEM than in DW-DMEM samples (Fig. 4B ).
However, since this decrease was small and delayed, thè total amount of sVEGF-A 24 kDa protein, as assessed by evaluating thè areas under thè respective curves, did not significantly differ in relation to thè type of growth medium considered (Fig. 3B) .
Thè sVEGF-A 20-kDa protein was thè second most abundant one secreted into either DW-or CW-DMEM, but its behaviour clearly differed according to thè type of medium used ( Fig. 4A and C) . In DW-DMEM (controls), sVEGF-A 20-kDa protein levels peaked at day 5 (at approximately twice that of starting levels: p<0.001), but rapidly fell to approx imately half of its opening values (p<0.001) at days 7 and 11 (Fig. 4C) . However, in CW-DMEM (treated cells), sVEGF-A 20-kDa protein levels at day 3 were much lower (-60%, p<0.001) than in DW-DMEM (Fig. 4C) . Moreover, sVEGF-A 20-kDa protein levels were also lower at day 5 (-68%, p<0.001) vs. corresponding DW-DMEM levels and kept falling (at day 11, -55%, p<0.00l vs. DW-DMEM values) (Fig. 4C ).
Thus, with respect to DW-DMEM medium, thè amount of sVEGF-A 20-kDa protein in CW-DMEM was severely reduced and, between days 3 and 11, was significantly less (-56.4%, p<0 .001) than in DW-DMEM samples (Fig. 3B) .
Thè sVEGF-A 15-kDa protein was thè least abundant one secreted into either DW-DMEM or CW-DMEM and, just like thè sVEGF-A 20-kDa protein, behaved quite differently according to thè kind of growth medium employed. In DW-DMEM (controls), sVEGF-A 15-kDa protein peaked at day 5 (a 3-fold surge over starting values: p<0.001) to fall between days 7 and 9 to levels slightly higher than thè initial ones (Fig. 4D) . However, in CW-DMEM, sVEGF-A 15-kDa protein levels were lower from thè outset than in thè alternative medium and remained such up to day 11 (e.g., -70%, p<0.001 at day 5) (Fig. 4D) . Thus, thè total amount of sVEGF-A 15-kDa protein released between days 3 and 11 into thè CW-DMEM
